New drug NTR-1011 tested for safety in lupus and arthritis patients
Disease control
Completed
This early-stage study tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The goal was to find a safe dose and see how the drug behaves in the body. The study was completed, but it is too early to know if the drug w…
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated May 17, 2026 12:30 UTC